-
-
-
-
-
-
-
Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction
-
-
-
-
-
-
-
Longeveron (LGVN) CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B in Mild Alzheimer’s Disease Accepted for Featured Research Session Oral Presentation at AAIC
-
-
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

